Daiwa Securities Group
IMMU

Daiwa Securities Group’s Immunomedics Inc IMMU Stock Holding History

Daiwa Securities Group’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,315
Closed -$112K – 1314
2020
Q3 		$112K Buy
1,315
+125
+11% +$6.32K ﹤0.01% 904
2020
Q2 		$16K Hold
1,190
– – ﹤0.01% 1040
2020
Q1 		$16K Buy
1,190
+99
+9% +$1.67K ﹤0.01% 1025
2019
Q4 		$23K Sell
1,091
-123
-10% -$2.17K ﹤0.01% 1004
2019
Q3 		$16K Hold
1,214
– – ﹤0.01% 1004
2019
Q2 		$17K Hold
1,214
– – ﹤0.01% 1023
2019
Q1 		$23K Sell
1,214
-126
-9% -$2.03K ﹤0.01% 985
2018
Q4 		$19K Buy
1,340
+500
+60% +$9.93K ﹤0.01% 971
2018
Q3 		$17K Hold
840
– – ﹤0.01% 1010
2018
Q2 		$20K Hold
840
– – ﹤0.01% 1011
2018
Q1 		$12K Buy
+840
New +$13.7K ﹤0.01% 1021

Daiwa Securities Group's IMMU Position: Q4 2020 in Review

Daiwa Securities Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,315 shares — an estimated $112K sold.

Daiwa Securities Group first reported a position in IMMU in Q1 2018 and held it in 11 quarters. The position peaked at $112K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Daiwa Securities Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 1,315 Immunomedics Inc shares in Q4 2020, an estimated $112K.
  • Daiwa Securities Group first reported a position in Immunomedics Inc in Q1 2018 and held it in 11 quarters.
  • Daiwa Securities Group's Immunomedics Inc position peaked at $112K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.